Nuvation Bio Appoints Philippe Sauvage as Chief Financial Officer
Slice of Healthcare Team
10/10/2024
Key Highlights
- Philippe Sauvage brings over 20 years of leadership in finance and operations within global biopharma and healthcare.
- Formerly Global Head of Operations and Access at Sanofi, overseeing market access and commercialization strategies.
- Led financial operations for Sanofi-Genzyme and Sanofi North America in a $14 billion region.
- Will support Nuvation Bio’s transition to a commercial-stage company by 2025.
Source: Business Wire
Notable Quotes
“ We are excited to welcome Philippe to Nuvation Bio at such an important stage of our evolution. ”
David Hung, M.D., Founder, President, and CEO at Nuvation Bio
“ I am thrilled to join Nuvation Bio as the team prepares for the potential commercialization of taletrectinib. ”
Philippe Sauvage, Chief Financial Officer at Nuvation Bio
